HEADER SIGNALING PROTEIN/AGONIST 09-AUG-22 8E0G TITLE RE-REFINED MODEL OF ACTIVE MU-OPIOID RECEPTOR (PDB 5C1M) AS AN ADDUCT TITLE 2 WITH BU72 CAVEAT 8E0G THR A 60 HAS WRONG CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: MU-TYPE OPIOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: M-OR-1,MOR-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NANOBODY 39; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: OPRM1, MOR, OPRM; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 11 ORGANISM_COMMON: LLAMA; SOURCE 12 ORGANISM_TAXID: 9844; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AGONIST, ACTIVE STATE, REVISED STRUCTURE, SIGNALING PROTEIN-AGONIST KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.A.MUNRO REVDAT 2 15-NOV-23 8E0G 1 LINK REVDAT 1 18-OCT-23 8E0G 0 JRNL AUTH T.A.MUNRO JRNL TITL REANALYSIS OF A MU OPIOID RECEPTOR CRYSTAL STRUCTURE REVEALS JRNL TITL 2 A COVALENT ADDUCT WITH BU72. JRNL REF BMC BIOL. V. 21 213 2023 JRNL REFN ESSN 1741-7007 JRNL PMID 37817141 JRNL DOI 10.1186/S12915-023-01689-W REMARK 0 REMARK 0 THIS ENTRY 8E0G REFLECTS AN ALTERNATIVE MODELING OF THE ORIGINAL REMARK 0 DATA IN 5C1M, DETERMINED BY W.J.HUANG,A.MANGLIK, REMARK 0 A.J.VENKATAKRISHNAN,T.LAEREMANS,E.N.FEINBERG,A.L.SANBORN, REMARK 0 H.E.KATO,K.E.LIVINGSTON,T.S.THORSEN,R.KLING,S.GRANIER,P.GMEINER, REMARK 0 S.M.HUSBANDS,J.R.TRAYNOR,W.I.WEIS,J.STEYAERT,R.O.DROR,B.K.KOBILKA REMARK 0 ORIGINAL DATA REFERENCE 1 REMARK 0 PDB ID: 5C1M REMARK 0 AUTH W.HUANG,A.MANGLIK,A.J.VENKATAKRISHNAN,T.LAEREMANS, REMARK 0 AUTH 2 E.N.FEINBERG,A.L.SANBORN,H.E.KATO,K.E.LIVINGSTON, REMARK 0 AUTH 3 T.S.THORSEN,R.C.KLING,S.GRANIER,P.GMEINER,S.M.HUSBANDS, REMARK 0 AUTH 4 J.R.TRAYNOR,W.I.WEIS,J.STEYAERT,R.O.DROR,B.K.KOBILKA REMARK 0 TITL STRUCTURAL INSIGHTS INTO MU-OPIOID RECEPTOR ACTIVATION. REMARK 0 REF NATURE V. 524 315 2015 REMARK 0 REFN ESSN 1476-4687 REMARK 0 PMID 26245379 REMARK 0 DOI 10.1038/NATURE14886 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PDB-REDO 7.32 REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 37971 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2775 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3276 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 131 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.02000 REMARK 3 B22 (A**2) : 3.63000 REMARK 3 B33 (A**2) : -2.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : RESIDUAL ONLY REMARK 4 REMARK 4 8E0G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 7.0-7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40051 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 43.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 8.500 REMARK 200 R MERGE (I) : 0.14200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.44510 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 5C1M REMARK 200 REMARK 200 REMARK: AUTHOR USED THE SF DATA FROM ENTRY 5C1M REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RECONSTITUTED IN 10:1 REMARK 280 MONOOLEIN:CHOLESTEROL MIX, PRECIPITANT: 15-25% PEG300, 100 MM REMARK 280 HEPES, PH 7.0-7.5, 1% 1,2,3-HEPTANETRIOL, 0.5-1.0% POLYPROPYLENE REMARK 280 GLYCOL P400, 100-300 MM AMMONIUM PHOSPHATE DIBASIC, PH 7.5, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.21500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 104.95000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 72.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 104.95000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.21500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 72.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 22.21500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 104.95000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 22.21500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 104.95000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 UNK B 103 REMARK 465 UNK B 104 REMARK 465 UNK B 105 REMARK 465 UNK B 106 REMARK 465 UNK B 107 REMARK 465 UNK B 108 REMARK 465 UNK B 109 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP B 53 CB TRP B 53 CG -0.141 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 205 CG - SD - CE ANGL. DEV. = -10.7 DEGREES REMARK 500 ARG B 72 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 59 -71.34 -101.71 REMARK 500 THR A 60 145.64 -37.74 REMARK 500 TYR A 96 -61.22 -100.33 REMARK 500 LYS A 98 -8.58 85.74 REMARK 500 MET A 99 30.81 70.13 REMARK 500 ARG A 179 45.99 -95.76 REMARK 500 ARG A 211 81.74 -160.61 REMARK 500 GLN A 212 51.04 73.27 REMARK 500 PHE A 241 -61.47 -122.24 REMARK 500 MET A 264 117.98 -173.58 REMARK 500 LEU A 265 -28.50 -37.69 REMARK 500 SER A 266 -61.67 -108.63 REMARK 500 SER A 268 -52.20 -174.81 REMARK 500 LYS A 344 -50.95 -29.91 REMARK 500 ARG B 29 19.99 59.69 REMARK 500 ALA B 126 -174.08 -61.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 401 REMARK 610 OLC A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5C1M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVE MU-OPIOID RECEPTOR BOUND TO THE AGONIST REMARK 900 BU72 DBREF 8E0G A 52 347 UNP P42866 OPRM_MOUSE 52 347 DBREF 8E0G B 3 127 PDB 8E0G 8E0G 3 127 SEQADV 8E0G U8S A 54 UNP P42866 HIS 54 CONFLICT SEQRES 1 A 296 GLY SER U8S SER LEU YCM PRO GLN THR GLY SER PRO SER SEQRES 2 A 296 MET VAL THR ALA ILE THR ILE MET ALA LEU TYR SER ILE SEQRES 3 A 296 VAL CYS VAL VAL GLY LEU PHE GLY ASN PHE LEU VAL MET SEQRES 4 A 296 TYR VAL ILE VAL ARG TYR THR LYS MET LYS THR ALA THR SEQRES 5 A 296 ASN ILE TYR ILE PHE ASN LEU ALA LEU ALA ASP ALA LEU SEQRES 6 A 296 ALA THR SER THR LEU PRO PHE GLN SER VAL ASN TYR LEU SEQRES 7 A 296 MET GLY THR TRP PRO PHE GLY ASN ILE LEU CYS LYS ILE SEQRES 8 A 296 VAL ILE SER ILE ASP TYR TYR ASN MET PHE THR SER ILE SEQRES 9 A 296 PHE THR LEU CYS THR MET SER VAL ASP ARG TYR ILE ALA SEQRES 10 A 296 VAL CYS HIS PRO VAL LYS ALA LEU ASP PHE ARG THR PRO SEQRES 11 A 296 ARG ASN ALA LYS ILE VAL ASN VAL CYS ASN TRP ILE LEU SEQRES 12 A 296 SER SER ALA ILE GLY LEU PRO VAL MET PHE MET ALA THR SEQRES 13 A 296 THR LYS TYR ARG GLN GLY SER ILE ASP CYS THR LEU THR SEQRES 14 A 296 PHE SER HIS PRO THR TRP TYR TRP GLU ASN LEU LEU LYS SEQRES 15 A 296 ILE CYS VAL PHE ILE PHE ALA PHE ILE MET PRO VAL LEU SEQRES 16 A 296 ILE ILE THR VAL CYS TYR GLY LEU MET ILE LEU ARG LEU SEQRES 17 A 296 LYS SER VAL ARG MET LEU SER GLY SER LYS GLU LYS ASP SEQRES 18 A 296 ARG ASN LEU ARG ARG ILE THR ARG MET VAL LEU VAL VAL SEQRES 19 A 296 VAL ALA VAL PHE ILE VAL CYS TRP THR PRO ILE HIS ILE SEQRES 20 A 296 TYR VAL ILE ILE LYS ALA LEU ILE THR ILE PRO GLU THR SEQRES 21 A 296 THR PHE GLN THR VAL SER TRP HIS PHE CYS ILE ALA LEU SEQRES 22 A 296 GLY TYR THR ASN SER CYS LEU ASN PRO VAL LEU TYR ALA SEQRES 23 A 296 PHE LEU ASP GLU ASN PHE LYS ARG CYS PHE SEQRES 1 B 125 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL ARG SEQRES 2 B 125 PRO GLY GLY SER LEU ARG LEU SER CYS VAL ASP SER GLU SEQRES 3 B 125 ARG THR SER TYR PRO MET GLY TRP PHE ARG ARG ALA PRO SEQRES 4 B 125 GLY LYS GLU ARG GLU PHE VAL ALA SER ILE THR TRP SER SEQRES 5 B 125 GLY ILE ASP PRO THR TYR ALA ASP SER VAL ALA ASP ARG SEQRES 6 B 125 PHE THR THR SER ARG ASP VAL ALA ASN ASN THR LEU TYR SEQRES 7 B 125 LEU GLN MET ASN SER LEU LYS HIS GLU ASP THR ALA VAL SEQRES 8 B 125 TYR TYR CYS ALA ALA ARG ALA PRO VAL UNK UNK UNK UNK SEQRES 9 B 125 UNK UNK UNK ASP TYR ASP TYR TRP GLY GLN GLY THR GLN SEQRES 10 B 125 VAL THR VAL SER SER ALA ALA ALA MODRES 8E0G YCM A 57 CYS MODIFIED RESIDUE HET U8S A 54 11 HET YCM A 57 10 HET OLC A 401 16 HET OLC A 402 18 HET CLR A 403 28 HET PO4 A 404 5 HET P6G A 405 19 HET PG4 A 406 13 HET VF1 A 407 32 HETNAM U8S 3-[(2S)-2-HYDROXY-2,3-DIHYDRO-1H-IMIDAZOL-4-YL]-L- HETNAM 2 U8S ALANINE HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM CLR CHOLESTEROL HETNAM PO4 PHOSPHATE ION HETNAM P6G HEXAETHYLENE GLYCOL HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM VF1 (2R,3S,3AR,5AR,6R,11BR,11CS)-3A-METHOXY-3,14-DIMETHYL- HETNAM 2 VF1 2-PHENYL-2,3,3A,6,7,11C-HEXAHYDRO-1H-6,11B- HETNAM 3 VF1 (EPIMINOETHANO)-3,5A-METHANONAPHTHO[2,1-G]INDOL-10-OL HETSYN YCM CYSTEINE-S-ACETAMIDE HETSYN OLC 1-OLEOYL-R-GLYCEROL HETSYN P6G POLYETHYLENE GLYCOL PEG400 HETSYN VF1 BU72 FORMUL 1 U8S C6 H11 N3 O3 FORMUL 1 YCM C5 H10 N2 O3 S FORMUL 3 OLC 2(C21 H40 O4) FORMUL 5 CLR C27 H46 O FORMUL 6 PO4 O4 P 3- FORMUL 7 P6G C12 H26 O7 FORMUL 8 PG4 C8 H18 O5 FORMUL 9 VF1 C28 H32 N2 O2 FORMUL 10 HOH *68(H2 O) HELIX 1 AA1 SER A 64 TYR A 96 1 33 HELIX 2 AA2 THR A 101 THR A 120 1 20 HELIX 3 AA3 THR A 120 GLY A 131 1 12 HELIX 4 AA4 PHE A 135 HIS A 171 1 37 HELIX 5 AA5 HIS A 171 ARG A 179 1 9 HELIX 6 AA6 THR A 180 MET A 205 1 26 HELIX 7 AA7 PRO A 224 PHE A 241 1 18 HELIX 8 AA8 PHE A 241 SER A 261 1 21 HELIX 9 AA9 SER A 268 ILE A 306 1 39 HELIX 10 AB1 THR A 311 ALA A 337 1 27 HELIX 11 AB2 ASP A 340 ARG A 345 1 6 HELIX 12 AB3 LYS B 87 THR B 91 5 5 SHEET 1 AA1 2 ALA A 206 ARG A 211 0 SHEET 2 AA1 2 SER A 214 LEU A 219 -1 O THR A 218 N THR A 207 SHEET 1 AA2 4 VAL B 7 SER B 9 0 SHEET 2 AA2 4 LEU B 20 VAL B 25 -1 O VAL B 25 N VAL B 7 SHEET 3 AA2 4 THR B 78 MET B 83 -1 O MET B 83 N LEU B 20 SHEET 4 AA2 4 PHE B 68 ASP B 73 -1 N THR B 69 O GLN B 82 SHEET 1 AA3 6 GLY B 12 VAL B 14 0 SHEET 2 AA3 6 THR B 118 VAL B 122 1 O THR B 121 N GLY B 12 SHEET 3 AA3 6 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 118 SHEET 4 AA3 6 TYR B 32 ARG B 39 -1 N TYR B 32 O ARG B 99 SHEET 5 AA3 6 GLU B 46 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 AA3 6 PRO B 58 TYR B 60 -1 O THR B 59 N SER B 50 SHEET 1 AA4 4 GLY B 12 VAL B 14 0 SHEET 2 AA4 4 THR B 118 VAL B 122 1 O THR B 121 N GLY B 12 SHEET 3 AA4 4 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 118 SHEET 4 AA4 4 TYR B 113 TRP B 114 -1 O TYR B 113 N ALA B 98 SSBOND 1 CYS A 140 CYS A 217 1555 1555 2.19 SSBOND 2 CYS B 24 CYS B 96 1555 1555 2.16 LINK C SER A 53 N U8S A 54 1555 1555 1.35 LINK C U8S A 54 N SER A 55 1555 1555 1.35 LINK O12 U8S A 54 NAS VF1 A 407 1555 1555 1.46 LINK C LEU A 56 N YCM A 57 1555 1555 1.35 LINK C YCM A 57 N PRO A 58 1555 1555 1.36 CISPEP 1 THR A 60 GLY A 61 0 12.02 CISPEP 2 HIS A 223 PRO A 224 0 -11.22 CISPEP 3 GLY A 267 SER A 268 0 13.71 CISPEP 4 CYS A 346 PHE A 347 0 -2.52 CRYST1 44.430 144.000 209.900 90.00 90.00 90.00 I 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022507 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006944 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004764 0.00000